Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Blood
26. November 2025
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8180
Articles 1 - 20 / 163591
PCK2, a SASP-Associated Gene, Serves as an Independent Prognostic Indicator in Diffuse Large B-Cell Lymphoma.
J Inflamm Res
Chen M, Pan Y, Zhang J, Zeng Y.
PMID: 41293647 [PubMed]
Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission.
Front Immunol
Sun Y, Deng M, Zhang C, Chen Y, Zhang Y, Zuo W.
PMID: 41293167 [PubMed - indexed for MEDLINE]
The continuing search for effective treatments for older adults with acute myeloid leukemia.
Expert Rev Clin Pharmacol
Thomas X.
PMID: 41292295 [PubMed - as supplied by publisher]
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies.
Eur J Haematol
Martino EA, Caserta S, Vigna E, Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F, Morabito F, Gentile M.
PMID: 41292288 [PubMed - as supplied by publisher]
CAR-DC combined with CAR-T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives.
Clin Transl Med
Zhang R, Zhang J, Zhang H, Zhao M.
PMID: 41292193 [PubMed - indexed for MEDLINE]
Early-stage Hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes.
BMC Cancer
Dawood S, McMillan B, Brown K, Oosthuizen J, Richardson D, Simba K, Andera LF, Opie J, Antel K, More S, Allie A, Mohamed Z, Verburgh E.
PMID: 41291557 [PubMed - in process]
NOTCH1 mutation status as a prognostic biomarker in T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.
BMC Cancer
Al Kuwari H, Al Khinji A, Al-Hamed D, Al Hor A, Malouche D, Iqbal J.
PMID: 41291497 [PubMed - in process]
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT.
Bone Marrow Transplant
Sanz J, Ferhat AT, Raiola AM, Blaise D, Arat M, Koc Y, Benakli M, Kwon M, Kulagin A, Parma M, Sica S, Tischer J, Pavlu J, Dhedin N, Grillo G, Kröger N, Montoro J, Giebel S, Peric Z, Savani B, Nagler A, Piemontese S, Mohty M, Ciceri F.
PMID: 41291114 [PubMed - as supplied by publisher]
Whole-body CD8(+) T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.
Nat Commun
de Boer JW, Keijzer K, van Doesum JA, Smit NAM, Brouwers AH, van Sluis J, Lub-de Hooge MN, Pierik FR, Huls GA, van Dijk LV, Visser L, Diepstra A, Noordzij W, Williams SP, Ungewickell A, Elias SG, de Vries EGE, Niezink AGH, van Meerten T.
PMID: 41290699 [PubMed - as supplied by publisher]
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide.
Blood Cancer J
Jen WY, Lachowiez CA, Marvin-Peek J, Altman JK, Yilmaz M, Garcia JS, Abaza Y, Short NJ, Zeidner JF, Daver NG, Wei AH, Issa GC, DiNardo CD.
PMID: 41290614 [PubMed - as supplied by publisher]
Effect of metabolic syndrome on prognosis in patients with peripheral T-cell lymphoma.
Hematology
Gao SQ, Li HB, Yang MZ, Sun RY, Zhang H, Li LR, Zhao WH, Zhang Y, Zhang QY, Zhao S.
PMID: 41289509 [PubMed - indexed for MEDLINE]
Patient health engagement as a predictor of symptom outcomes in patients receiving chemotherapy.
Support Care Cancer
Fridriksdottir N, Ingadottir B, Zoëga S, Gunnarsdottir S.
PMID: 41288766 [PubMed - indexed for MEDLINE]
Current Therapeutic Strategies for FLT3-Mutated Acute Myeloid Leukemia: A Narrative Review.
Cureus
Swanson L, Sharp J, Liaw A, Abi Abdallah D, Duriancik DM.
PMID: 41287669 [PubMed]
Study on the regulation of Treg cell infiltration by EZH2 through CXCR4/CXCL12 in diffuse large B-cell lymphoma.
Clin Exp Med
Wang H, Liang D, Qian Y, Jiang Y, Yang R, Yin H.
PMID: 41286377 [PubMed - indexed for MEDLINE]
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
Ho C, Kennedy N, Di M, Gopal AK, Lynch RC, Ng K, Wu QV, Poh C, Raghunathan V, Rasmussen H, Shadman M, Till BG, Ujjani CS, Smith SD.
PMID: 41285650 [PubMed - as supplied by publisher]
Construction of a deep learning model and identification of BSG, PPARD, and SLC16A8 expression as potential indicators in the context of strategies for precision therapy to acute myeloid leukemia.
Hematology
Chen Y, Liang B, He R, Zhang Z.
PMID: 41284982 [PubMed - indexed for MEDLINE]
Current status of hematopoietic cell transplantation in patients with peripheral T-cell lymphoma including adult T-cell leukemia-lymphoma.
Int J Hematol
Fuji S, Ohmoto A.
PMID: 41283963 [PubMed - as supplied by publisher]
MECOM-Rearranged Acute Myeloid Leukemia: Pathobiology and Management Strategies.
Hematol Rep
Joshi U, Shallis RM.
PMID: 41283235 [PubMed]
Comparison of anti-PD-1/PD-L1-based regimens in relapsed/refractory diffuse large B-cell lymphoma: a meta-analysis.
PeerJ
Jiang W, Wen T, Liu P.
PMID: 41282995 [PubMed - indexed for MEDLINE]
Evaluation of Efficacy, Safety, and Prognostic Value of Induction Chemotherapy in Patients with Acute Myeloid Leukemia: An Updated Meta-Analysis of a 5-Year Study.
Int J Hematol Oncol Stem Cell Res
Komara IMAN, Suega K, Rena NMRA, Adnyana IWL.
PMID: 41281793 [PubMed]
Articles 1 - 20 / 163591
Page 1 of 8180
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy